Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016343

Options or other derivatives

  • President and CEO acquired 725,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Browne Leslie J · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-11-17 Grant or award : show line 1 in the form Common Stock Option +725,000 $0.26 2020-11-17 725,000 1,725,000 D
Loading xslF345X03/edgar.xml…